Page last updated: 2024-10-21

3-aminobenzamide and Benign Neoplasms, Brain

3-aminobenzamide has been researched along with Benign Neoplasms, Brain in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Temozolomide (TZM) is a novel methylating agent currently under investigation for treatment of recurrent high-grade gliomas."7.71Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells. ( Graziani, G; Navarra, P; Portarena, I; Scerrati, M; Tentori, L; Torino, F, 2002)
"Temozolomide (TZM) is a novel methylating agent currently under investigation for treatment of recurrent high-grade gliomas."3.71Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells. ( Graziani, G; Navarra, P; Portarena, I; Scerrati, M; Tentori, L; Torino, F, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tentori, L1
Portarena, I1
Torino, F1
Scerrati, M1
Navarra, P1
Graziani, G1
Lee, YW1
Ha, MS1
Kim, YK1

Other Studies

2 other studies available for 3-aminobenzamide and Benign Neoplasms, Brain

ArticleYear
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G(2)/M cell accumulation induced by temozolomide in malignant glioma cells.
    Glia, 2002, Volume: 40, Issue:1

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Brain

2002
H2O2-induced cell death in human glioma cells: role of lipid peroxidation and PARP activation.
    Neurochemical research, 2001, Volume: 26, Issue:4

    Topics: Benzamides; Brain Neoplasms; Cell Death; Dithiothreitol; Enzyme Activation; Enzyme Inhibitors; Free

2001